Loading...
Please wait, while we are loading the content...
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients.
| Content Provider | Europe PMC |
|---|---|
| Author | Hydbring, Per |
| Copyright Year | 2023 |
| ISSN | 22186751 |
| Journal | Translational Lung Cancer Research |
| Volume Number | 12 |
| PubMed Central reference number | PMC10087993 |
| Issue Number | 3 |
| PubMed reference number | 37057104 |
| e-ISSN | 22264477 |
| DOI | 10.21037/tlcr-23-117 |
| Language | English |
| Publisher | AME Publishing Company |
| Publisher Date | 2023-03-17 |
| Access Restriction | Open |
| Rights License | Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0. 2023 Translational Lung Cancer Research. All rights reserved. |
| Subject Keyword | Lung adenocarcinoma epidermal growth factor receptor (EGFR) osimertinib immune-related proteins immune-related gene sets |
| Content Type | Text |
| Resource Type | Article |
| Subject | Oncology |